Literature DB >> 30109445

Extra-renal manifestations of atypical hemolytic uremic syndrome.

Cassandra Formeck1, Agnieszka Swiatecka-Urban2.   

Abstract

Atypical hemolytic uremic syndrome (aHUS) is a rare and complex disease resulting from abnormal alternative complement activation with a wide range of clinical presentations. Extra-renal manifestations of aHUS can involve many organ systems, including the peripheral and central nervous, gastrointestinal, cardiovascular, integumentary, pulmonary, as well as the eye. While some of these extra-renal manifestations occur in the acute phase of aHUS, some can also occur as long-term sequelae of unopposed complement activation. Extra-renal symptoms are observed in approximately 20% of patients with aHUS, with the incidence of specific organ system complications ranging from a few case reports to 50% of described patients. Careful monitoring for extra-renal involvement is critical in patients with aHUS, as prompt evaluation and management may decrease the risk of high morbidity and mortality associated with aHUS.

Entities:  

Keywords:  Atypical hemolytic-uremic syndrome (aHUS); Cardiovascular complications; Extra-renal manifestations; Gastrointestinal complications; Neurologic complications; Thrombotic microangiopathy (TMA)

Mesh:

Year:  2018        PMID: 30109445     DOI: 10.1007/s00467-018-4039-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  56 in total

1.  Non-atheromatous arterial stenoses in atypical haemolytic uraemic syndrome associated with complement dysregulation.

Authors:  Chantal Loirat; Marie-Alice Macher; Monique Elmaleh-Berges; Theresa Kwon; Georges Deschênes; Timothy H J Goodship; Charles Majoie; Jean-Claude Davin; Raphael Blanc; Julien Savatovsky; Jacques Moret; Véronique Fremeaux-Bacchi
Journal:  Nephrol Dial Transplant       Date:  2010-06-08       Impact factor: 5.992

2.  Proximal cerebral artery stenosis in a patient with hemolytic uremic syndrome.

Authors:  M D I Vergouwen; K S Adriani; Y B W E M Roos; J W Groothoff; C B L M Majoie
Journal:  AJNR Am J Neuroradiol       Date:  2008-02-07       Impact factor: 3.825

3.  Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

Authors:  Marina Noris; Jessica Caprioli; Elena Bresin; Chiara Mossali; Gaia Pianetti; Sara Gamba; Erica Daina; Chiara Fenili; Federica Castelletti; Annalisa Sorosina; Rossella Piras; Roberta Donadelli; Ramona Maranta; Irene van der Meer; Edward M Conway; Peter F Zipfel; Timothy H Goodship; Giuseppe Remuzzi
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

4.  Peripheral gangrene in children with atypical hemolytic uremic syndrome.

Authors:  Michal Malina; Ashima Gulati; Arvind Bagga; Mohammad A Majid; Eva Simkova; Franz Schaefer
Journal:  Pediatrics       Date:  2012-12-10       Impact factor: 7.124

Review 5.  The Alternative Pathway of Complement and the Evolving Clinical-Pathophysiological Spectrum of Atypical Hemolytic Uremic Syndrome.

Authors:  Bruce E Berger
Journal:  Am J Med Sci       Date:  2016-05-09       Impact factor: 2.378

6.  Peripheral gangrene complicating hemolytic uremic syndrome in a child.

Authors:  Ahmet Ozel; Umran Calişkan; Safak Gücer
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

Review 7.  STEC-HUS, atypical HUS and TTP are all diseases of complement activation.

Authors:  Marina Noris; Federica Mescia; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

8.  Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.

Authors:  Jean-Claude Davin; Valentina Gracchi; Antonia Bouts; Jaap Groothoff; Lisa Strain; Tim Goodship
Journal:  Am J Kidney Dis       Date:  2009-10-25       Impact factor: 8.860

9.  Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome.

Authors:  J E Ramos de Carvalho; R O Schlingemann; M Oranje; F J Bemelman; M J van Schooneveld
Journal:  Int Ophthalmol       Date:  2017-03-08       Impact factor: 2.031

10.  Case report of atypical hemolytic uremic syndrome with retinal arterial and venous occlusion treated with eculizumab.

Authors:  Gregory T Greenwood
Journal:  Int Med Case Rep J       Date:  2015-10-13
View more
  12 in total

1.  Thrombotic microangiopathy following aortic surgery with hypothermic circulatory arrest: a single-centre experience of an underestimated cause of acute renal failure.

Authors:  Christine E Kamla; Melissa Grigorescu-Vlass; Dietmar Wassilowsky; Michael Fischereder; Christian Hagl; Ulf Schönermarck; Maximilian A Pichlmaier; Sven Peterss; Dominik Jóskowiak
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-01-18

2.  Unusual eye findings in a patient with atypical hemolytic uremic syndrome: Answers.

Authors:  Begüm Avcı; Şengül Özdek; İmren Akkoyun; Esra Baskın
Journal:  Pediatr Nephrol       Date:  2022-01-27       Impact factor: 3.651

3.  Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.

Authors:  Laura Bianchi; Federica Gaiani; Francesca Vincenzi; Stefano Kayali; Francesco Di Mario; Gioacchino Leandro; Gian Luigi De' Angelis; Claudio Ruberto
Journal:  Acta Biomed       Date:  2018-12-17

4.  Occlusive retinal vasculopathy with macular branch retinal artery occlusion as a leading sign of atypical hemolytic uremic syndrome - a case report.

Authors:  David Pérez González; Matias Iglicki; Shuli Svetitsky; Yaeli Bar-On; Zohar Habot-Wilner; Dinah Zur
Journal:  BMC Ophthalmol       Date:  2021-01-30       Impact factor: 2.209

5.  Atypical hemolytic uremic syndrome in the Colombian Caribbean: its particular characteristics.

Authors:  Omar Cabarcas-Barbosa; Gustavo Aroca-Martínez; Carlos G Musso; Elizabeth Ramos-Bolaños; Henry González-Tórres; Zilac Espitaleta-Vergara; Alex Domínguez-Vargas; Edufamir Ararat-Rodriguez; José Orozco; Luis Castillo-Parodi; Juan Conde-Manotas; Rodrigo Daza-Arnedo; Víctor Rodríguez-SanJuan; Liliana Gómez-Navarro; Roberto Acosta-Madiedo; Luis Barros-Camargo; Angélica Aduen-Carrillo; Francisco Ayola-Anaya; María Pulgar-Emiliani; Andrés Cadena-Bonfanti
Journal:  Int Urol Nephrol       Date:  2021-10-13       Impact factor: 2.266

6.  Clinical Observation on the Nursing Effect of Mindfulness-Based Stress Reduction Combined with Solution-Focused Brief Therapy in Uremic Peritoneal Dialysis Patients and Influence on Nutritional Status.

Authors:  Yiqian Wang; Huazhi Lin; Lihua Wang; Jun Cao; Dan Zheng; Jing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-24       Impact factor: 2.629

7.  Complement inhibitor eculizumab in thrombotic microangiopathy: Single-center case series.

Authors:  Monika Vitkauskaitė; Artūras Vinikovas; Marius Miglinas; Laurynas Rimševičius; Agnė Čerkauskaitė; Ernesta Mačionienė; Eglė Ašakienė
Journal:  Clin Case Rep       Date:  2022-03-15

8.  Renal Damage in Recurrent Atypical Hemolytic Uremic Syndrome Associated with C3 p.Ile1157Thr Gene Mutation.

Authors:  Masahiro Okabe; Arisa Kobayashi; Hirokazu Marumoto; Kentaro Koike; Izumi Yamamoto; Tetsuya Kawamura; Nobuo Tsuboi; Takashi Yokoo
Journal:  Intern Med       Date:  2020-10-21       Impact factor: 1.271

Review 9.  Pediatric Atypical Hemolytic Uremic Syndrome Advances.

Authors:  Rupesh Raina; Nina Vijayvargiya; Amrit Khooblall; Manasa Melachuri; Shweta Deshpande; Divya Sharma; Kashin Mathur; Manav Arora; Sidharth Kumar Sethi; Sonia Sandhu
Journal:  Cells       Date:  2021-12-18       Impact factor: 7.666

10.  Hemolytic Uremic Syndrome in Children.

Authors:  Bora Gülhan; Fatih Özaltın
Journal:  Turk Arch Pediatr       Date:  2021-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.